Jianzhuang Wu

Oncogenic KRAS signaling drives evasion of innate immune surveillance in lung adenocarcinoma by activating CD47

Huanhuan Hu, Rongjie Cheng, Yanbo Wang et al. · Journal of Clinical Investigation · 2022 · 105 citations · Full text

Medicine, Cancer Biology, Oncology +17

A novel protein RASON encoded by a lncRNA controls oncogenic RAS signaling in KRAS mutant cancers

Rongjie Cheng, Fanying Li, Maolei Zhang et al. · Cell Research · 2022 · 103 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Hesperadin suppresses pancreatic cancer through ATF4/GADD45A axis at nanomolar concentrations

Yixuan Zhang, Jianzhuang Wu, Yao Fu et al. · Oncogene · 2022 · 31 citations

Medicine, Cancer Biology, Oncology +9

Design, synthesis, and evaluation of 4(1H)-quinolinone and urea derivatives as KRASG12C inhibitors with potent antitumor activity against KRAS-mutant non-small cell lung cancer

Rongjie Cheng, Xiashi Lv, Huagang Bu et al. · European Journal of Medicinal Chemistry · 2022 · 12 citations

Pharmacy, Medicinal Chemistry, Oncology +12

Protein‐Targeted Glycan Editing on Living Cells Disrupts KRAS Signaling

Yiran Li, Fan Huo, Liusheng Chen et al. · Angewandte Chemie International Edition · 2023 · 12 citations

Life Sciences, Molecular Biology, Oncology +17